ArticleClinical and translational medicine2020

Combinatorial assessment of ctDNA release and mutational burden predicts anti-PD(L)1 therapy outcome in nonsmall-cell lung cancer.

Wenfeng Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.